Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease (Q73961084)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

E Trenkwalder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Gruber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P König

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H Dieplinger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

F Kronenberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

1685-1692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9407518%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1997.503

8 November 2019

exact match

0 references

cites work

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Lipoprotein(a) in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Lipoprotein(a) in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Atherosclerosis and arteriosclerosis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Urinary Excretion of Apo(a) Fragments

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

The assembly of lipoprotein Lp(a).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Apo(a) isoforms predict risk for coronary heart disease. A study in six populations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Does cyclosporin affect lipoprotein(a) concentrations?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": the role of kringle IV sequences in the extracellular association with low-density lipoprotein.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021

Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.503

7 January 2021